Cargando…
KRAS Mutation Test in Korean Patients with Colorectal Carcinomas: A Methodological Comparison between Sanger Sequencing and a Real-Time PCR-Based Assay
BACKGROUND: Mutations in the KRAS gene have been identified in approximately 50% of colorectal cancers (CRCs). KRAS mutations are well established biomarkers in anti–epidermal growth factor receptor therapy. Therefore, assessment of KRAS mutations is needed in CRC patients to ensure appropriate trea...
Autores principales: | Lee, Sung Hak, Chung, Arthur Minwoo, Lee, Ahwon, Oh, Woo Jin, Choi, Yeong Jin, Lee, Youn-Soo, Jung, Eun Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267542/ https://www.ncbi.nlm.nih.gov/pubmed/28013534 http://dx.doi.org/10.4132/jptm.2016.10.03 |
Ejemplares similares
-
Identification of a Clinical Cutoff Value for Multiplex KRAS(G12/G13) Mutation Detection in Colorectal Adenocarcinoma Patients Using Digital Droplet PCR, and Comparison with Sanger Sequencing and PNA Clamping Assay
por: Lee, Kyung Ha, et al.
Publicado: (2020) -
The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
por: Won, Daeyoun David, et al.
Publicado: (2017) -
Genetic Testing Requires NGS and Sanger Methodologies
por: Jennings, Lawrence J., et al.
Publicado: (2016) -
Screening PCR Versus Sanger Sequencing: Detection of CALR Mutations in Patients With Thrombocytosis
por: Jeong, Ji Hun, et al.
Publicado: (2016) -
SensiScreen(®)
KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations
por: Riva, Alice, et al.
Publicado: (2017)